Vala Sciences Inc.
San Diego, CA
- UEI
- CZZJVX2BKJF3
- CAGE
- 47YK2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 6190 Cornerstone Ct E # 101, San Diego, CA 92121, USA
- Website
- valasciences.com
- Founded
- 2004
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $300,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Scripps Research Institute | R01DA053801 | $150,000 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Curi Bio Inc. | Seattle, WA | 334516 Analytical Laboratory Instrument Manufacturing |
| Brainxell, Inc. | Madison, WI | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Endomimetics, Inc. | Birmingham, AL | — |
| Neucyte Inc. | Mountain View, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Modulo Bio, Inc. | San Diego, CA | — |
About the company
Vala Sciences Inc. is a for-profit corporate entity based in San Diego, California, specializing in advanced biomedical research and development, with a particular focus on creating sophisticated cell-based assay platforms and screening technologies for pharmaceutical and medical research. The company develops innovative in vitro models and high-throughput screening systems utilizing human induced pluripotent stem cell (hiPSC) derived neural, cardiac, and pain-related cell models. Registered in SAM.gov since 2005, Vala Sciences demonstrates expertise in developing complex cellular screening platforms that leverage advanced digital microscopy, kinetic image cytometry, and artificial intelligence technologies to evaluate potential therapeutic compounds and assess neurotoxicity, cardiotoxicity, and other critical biological mechanisms.
Through its federal contract work, Vala Sciences has demonstrated capabilities in Small Business Innovation Research (SBIR) programs, specifically focusing on developing novel research models. For instance, the company received a $300,000 firm-fixed-price contract from the National Institute on Drug Abuse (NIDA) to develop in-vitro and in-vivo models supporting NeuroHIV research. The contract was set aside for small businesses and aims to create advanced research methodologies for understanding neurological impacts of HIV. While the provided documentation does not extensively detail multiple contract awards, the SBIR contract highlights the company's commitment to innovative research development in neurological and medical domains.
Regarding federal grant awards, Vala Sciences has secured multiple significant grants from various National Institutes of Health (NIH) components, focusing on developing advanced human cell-based assay platforms. These grants include a $2,434,186 award from the National Institute of Environmental Health Sciences to develop in vitro assays for testing developmental neurotoxicity, a grant from the National Institute of Mental Health to create neural circuit screening platforms, a National Institute of Neurological Disorders and Stroke grant for developing a "Pain in a Dish" assay to screen potential non-opioid analgesics, and a National Heart, Lung, and Blood Institute grant for creating a cardiotoxicity clinical trials-in-a-dish platform. Each grant demonstrates the company's sophisticated approach to developing human cell-derived screening technologies that can potentially revolutionize preclinical drug testing across multiple medical research domains.
SBA capabilities narrative
Cardiotoxicity, Neurotoxicity, Histology, Migration & wound healing, Antibody validation, high content screening services, lipid metabolism, cell-cell junction, custom assays
Quick answers
Is Vala Sciences Inc. registered in SAM.gov?
Yes. Vala Sciences Inc.'s SAM.gov registration is active through December 22, 2026.
How much has Vala Sciences Inc. received in federal contracts?
Federal contracts obligated $300,000 to Vala Sciences Inc. in fiscal years 2023 through 2027.
What is Vala Sciences Inc.'s most recent federal award?
Vala Sciences Inc.'s most recent federal contract award is Sbir phase 1 (NIH/nimh topic 002 - development of novel in-vitro and in-vivo models to support neurohiv research)… (75N95024C00035), from National Institute on Drug Abuse (NIH), on September 27, 2024.
On GovTribe
See Vala Sciences Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors